RE: Santa rally18 Dec 2020 08:54
Tying in with Mark and Seamus' interest in VELA : -
FROM INVEST.COM 45 MINS AGO :-
Vela Technologies [LON:VELA] provides an update this morning on its therapy to treat diabetic patients suffering from COVID-19. Although there’s no early data out from the trial, it notes that the drug is tolerated well and again as with Synairgen’s comment, adds that even with vaccines being rolled out, this offers no comprehensive guarantee of protection and alternate therapies will have a role to play.